Skip to main content

William Bonello

NeoGenomics has appointed William Bonello VP of strategy, corporate development and investor relations. Bonello has served as the company's VP, treasurer, and director of corporate development since April of last year. Previously Bonello worked as a healthcare equity analyst covering diagnostic services and product stocks for Craig-Hallum, and as an equity analyst for Piper Jaffray, Wachovia Securities, and RBC Capital Markets. Bonello was also previously senior VP for investor relations at Laboratory Corporation of America.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.